Graft Polymer Appoints Top Neuroscience Expert
Company Announcements

Graft Polymer Appoints Top Neuroscience Expert

Graft Polymer (UK) PLC (GB:GPL) has released an update.

Graft Polymer (UK) PLC has bolstered its scientific leadership by appointing renowned neuroscience and public health authority Professor David Nutt as its Senior Scientific Adviser. Nutt, who is deeply involved in UK drug policy and mental health treatment research, brings a wealth of experience from his roles at Imperial College London and Awakn Life Sciences Corp. His expertise is expected to greatly contribute to Graft Polymer’s mission of pioneering innovative drug delivery solutions.

For further insights into GB:GPL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskGraft Polymer Advances PTSD Therapeutic Research
TipRanks UK Auto-Generated NewsdeskGraft Polymer Advances PTSD Treatment Research
TipRanks UK Auto-Generated NewsdeskGraft Polymer Welcomes New Chairman
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App